Companies on the Program Include:
The 6th RNAi-Based Therapeutics Summit!
Accelerating the Clinical Approval of the Next Wave of RNAi Medicines
As innovative drug delivery platforms beyond GalNac continued to emerge and novel chemical modifications were discovered, the potential for RNAi therapeutics to treat a plethora of diseases grew. More than ever, RNAi therapies held promise to treat diseases beyond the liver and provide efficacious, tolerable treatment options for patients.
The 6th RNAi-Based Therapeutics Summit returned to Boston to showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools that assisted payload design, and breakthrough chemical modifications which enhance stability, allowing for precise therapeutic delivery.
Uniting 70+ leaders of the RNAi world, this Summit empowered experts to pioneer their RNAi candidates into clinically successful therapies. Bringing together technical and strategic experts from Novo Nordisk, Alynlam Therapeutics, Judo Bio, Aro Biotherapeutics, Novartis, Comanche Biopharma and more, this meeting was a unique gathering of RNAi’s sharpest minds, dedicated to progressing the next wave of RNAi therapeutics to improve healthcare for patients in need.
DOWNLOAD THE BROCHURE
What You Missed:
New Data on Exciting Extra-Hepatic Targets including insights from Comanche Biopharma that assisted cell migration and wound repair from MicroCures, and clinical data from Novo Nordisk on immune cell targeting with RNAi-lipid conjugates
Fresh Insights & A New Expert Speaker Faculty comprised of leaders from R&D, translation, and manufacturing, including brand-new companies like ProteinQure, Avidity Biosciences and SanegeneBio who spoke for the first time. All speakers shared brand-new data or updates on their RNAi candidates
A New Focus on Securing Investment and Attracting Industry Partnerships to maximize the success of early-stage RNAi assets and platforms, with expertise from Sunrise Bioventures and Broadview Ventures. Attendees asked the questions they needed answering to transform their research into clinical success
Our Expert Speakers Included:
Our 2025 Partners
What Do Your Peers Have to Say?
